Correlation Between Unitech Computer and Alar Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unitech Computer and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unitech Computer and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unitech Computer Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on Unitech Computer and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unitech Computer with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unitech Computer and Alar Pharmaceuticals.

Diversification Opportunities for Unitech Computer and Alar Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Unitech and Alar is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Unitech Computer Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Unitech Computer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unitech Computer Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Unitech Computer i.e., Unitech Computer and Alar Pharmaceuticals go up and down completely randomly.

Pair Corralation between Unitech Computer and Alar Pharmaceuticals

Assuming the 90 days trading horizon Unitech Computer Co is expected to under-perform the Alar Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Unitech Computer Co is 1.83 times less risky than Alar Pharmaceuticals. The stock trades about -0.21 of its potential returns per unit of risk. The Alar Pharmaceuticals is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  14,600  in Alar Pharmaceuticals on October 9, 2024 and sell it today you would lose (650.00) from holding Alar Pharmaceuticals or give up 4.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Unitech Computer Co  vs.  Alar Pharmaceuticals

 Performance 
       Timeline  
Unitech Computer 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Unitech Computer Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Unitech Computer is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Alar Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alar Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Unitech Computer and Alar Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unitech Computer and Alar Pharmaceuticals

The main advantage of trading using opposite Unitech Computer and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unitech Computer position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.
The idea behind Unitech Computer Co and Alar Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance